Recursion Pharmaceuticals RXRX shares have plunged 21.6% so far in May. This considerable decline in the stock was observed ...

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now.

We recently published a list of the 13 Best Artificial Intelligence Stocks Under $50 to Buy Now. In this article, we are ...

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it ...

Shares of Recursion Pharmaceuticals ( RXRX -1.48%) fell this week. The stock lost 24% as of market close on Friday. The move ...

is a clinical-stage biotech company that uses AI and ML to develop novel therapeutics. The company’s AI-driven drug discovery platform is called the Recursion Operating System/OS. This platform ...

Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find out why RXRX stock is a buy.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top ...

Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets.

However, Recursion Pharmaceuticals’ solid fundamentals and the promising potential of its AI-driven drug discovery platform, Recursion OS, developed in collaboration with NVIDIA Corporation ...